WO1997014797A3 - Nouvel inhibiteur de cysteine proteinase, la cystatine m - Google Patents
Nouvel inhibiteur de cysteine proteinase, la cystatine m Download PDFInfo
- Publication number
- WO1997014797A3 WO1997014797A3 PCT/US1996/016782 US9616782W WO9714797A3 WO 1997014797 A3 WO1997014797 A3 WO 1997014797A3 US 9616782 W US9616782 W US 9616782W WO 9714797 A3 WO9714797 A3 WO 9714797A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cystatin
- nucleic acid
- cysteine proteinase
- acid molecules
- proteinase inhibitor
- Prior art date
Links
- 102000015833 Cystatin Human genes 0.000 title abstract 2
- 102100028007 Cystatin-SA Human genes 0.000 title abstract 2
- 101710144510 Cysteine proteinase inhibitor Proteins 0.000 title abstract 2
- 108050004038 cystatin Proteins 0.000 title abstract 2
- 239000002852 cysteine proteinase inhibitor Substances 0.000 title abstract 2
- 108010061617 Cystatin M Proteins 0.000 abstract 4
- 102000012177 Cystatin M Human genes 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 108010005843 Cysteine Proteases Proteins 0.000 abstract 1
- 102000005927 Cysteine Proteases Human genes 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108090000526 Papain Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001394 metastastic effect Effects 0.000 abstract 1
- 206010061289 metastatic neoplasm Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000019834 papain Nutrition 0.000 abstract 1
- 229940055729 papain Drugs 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Molécules d'acide nucléique isolées codant un nouvel inhibiteur de cystéine protéinase, la cystatine M, qui est un membre des cystatines de la famille 2. La cystatine M présente une activité inhibitrice de la cystéine protéinase contre la papaïne, est régulée à la baisse dans les cellules tumorales épithéliales mammaires métastasiques, ainsi que dans d'autres cellules tumorales, et est régulée à la hausse dans les cellules sénescentes. Outre des molécules isolées d'acide nucléique, la présente invention concerne des molécules d'acide nucléique antisens, des vecteurs d'expression de recombinaison contenant une molécule d'acide nucléique de la présente invention, des cellules hôtes dans lesquelles les vecteurs d'expression ont été introduits et des animaux transgéniques non humains dans lesquels un gène de cystatine M a été introduit ou dissocié. La présente invention concerne encore des protéines de cystatine M, des protéines de fusion, des peptides antigéniques et des anticorps anti-cystatine M isolés. Des procédés de diagnostique, d'analyse et thérapeutiques utilisant des compositions de la présente invention sont également décrits.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU74579/96A AU7457996A (en) | 1995-10-20 | 1996-10-18 | Cystatin m, a novel cysteine proteinase inhibitor |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54600095A | 1995-10-20 | 1995-10-20 | |
| US08/546,000 | 1995-10-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| WO1997014797A2 WO1997014797A2 (fr) | 1997-04-24 |
| WO1997014797A3 true WO1997014797A3 (fr) | 1997-10-02 |
| WO1997014797A9 WO1997014797A9 (fr) | 1997-10-30 |
Family
ID=24178431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1996/016782 WO1997014797A2 (fr) | 1995-10-20 | 1996-10-18 | Nouvel inhibiteur de cysteine proteinase, la cystatine m |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7457996A (fr) |
| WO (1) | WO1997014797A2 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171790B1 (en) * | 1998-05-01 | 2001-01-09 | Incyte Pharmaceuticals, Inc. | Human protease associated proteins |
| US6001596A (en) * | 1998-05-07 | 1999-12-14 | Incyte Pharmaceuticals, Inc. | Growth-associated protease inhibitor heavy chain precursor |
| JP4592127B2 (ja) * | 1999-03-30 | 2010-12-01 | 雪印乳業株式会社 | 骨吸収抑制剤 |
| US6366762B1 (en) * | 1999-03-31 | 2002-04-02 | Qualcomm, Inc. | System and method for measuring round trip delay on the paging and access channels |
| CA2374745A1 (fr) * | 1999-08-09 | 2001-02-15 | Incyte Genomics, Inc. | Proteases et inhibiteurs de proteases |
| US6943277B2 (en) | 2000-07-11 | 2005-09-13 | Deltagen, Inc. | Transgenic mice containing stefin homolog protease inhibitor gene disruptions |
| AU2001273352A1 (en) * | 2000-07-11 | 2002-01-21 | Deltagen, Inc. | Transgenic mice containing targeted protease inhibitor gene disruptions |
| AU2003202689A1 (en) | 2002-01-23 | 2003-09-09 | El-Gewely, Mohamed, Raafat | Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53 |
| CN112379093B (zh) * | 2020-10-22 | 2023-06-16 | 上海良润生物医药科技有限公司 | CST-Cathepsin复合物作为肿瘤诊断标志物的应用 |
| CN113957077B (zh) * | 2021-10-18 | 2023-05-16 | 中国热带农业科学院环境与植物保护研究所 | 一种剑麻半胱氨酸蛋白酶抑制剂基因及应用 |
| CN116023472A (zh) * | 2023-02-20 | 2023-04-28 | 大连工业大学 | 一种高效表达生产半胱氨酸蛋白酶抑制剂的方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3724581A1 (de) * | 1987-07-24 | 1989-02-02 | Gruenenthal Gmbh | Dna-sequenzen, die fuer proteine mit den biologischen eigenschaften des cystatin c codieren, herstellung dieser dna-sequenzen, expression des cystatin c sowie dieses enthaltende pharmazeutische zubereitungen |
| JPH07126294A (ja) * | 1993-04-28 | 1995-05-16 | Snow Brand Milk Prod Co Ltd | 新規システインプロテアーゼインヒビター |
-
1996
- 1996-10-18 AU AU74579/96A patent/AU7457996A/en not_active Abandoned
- 1996-10-18 WO PCT/US1996/016782 patent/WO1997014797A2/fr active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3724581A1 (de) * | 1987-07-24 | 1989-02-02 | Gruenenthal Gmbh | Dna-sequenzen, die fuer proteine mit den biologischen eigenschaften des cystatin c codieren, herstellung dieser dna-sequenzen, expression des cystatin c sowie dieses enthaltende pharmazeutische zubereitungen |
| JPH07126294A (ja) * | 1993-04-28 | 1995-05-16 | Snow Brand Milk Prod Co Ltd | 新規システインプロテアーゼインヒビター |
Non-Patent Citations (3)
| Title |
|---|
| DATABASE WPI Week 9528, Derwent World Patents Index; AN 95-212959, XP002031097 * |
| EMBL DATABASE, Accession no U62800. 26 Aug1996. SOTIROPOULOU G. et al: "Identification, cloning and characterization of cystatin M...." * |
| SOTIROPOULOU G ET AL: "Isolation of a novel protease inhibitor involved in breast cancer and senescence.", 1ST WORLD CONGRESS ON ADVANCES IN ONCOLOGY, ATHENS, GREECE, OCTOBER 22-26, 1995. INTERNATIONAL JOURNAL OF ONCOLOGY 7 (SUPPL.). 1995. 969. ISSN: 1019-6439, XP000672818 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997014797A2 (fr) | 1997-04-24 |
| AU7457996A (en) | 1997-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001073059A3 (fr) | 38692 et 21117, nouvelles molecules de phosphatase a double specificite et leurs utilisations | |
| WO1997014797A3 (fr) | Nouvel inhibiteur de cysteine proteinase, la cystatine m | |
| WO1998011238A3 (fr) | Protease m, une nouvelle serine protease | |
| WO2002006302A3 (fr) | Nouvelles molecules humaines de phospholipases c, 16816 et 16839, et utilisations correspondantes | |
| WO2001092493A3 (fr) | Nouvelles aminopeptidases humaines 21956 et 25856, et utilisations | |
| WO2000008045A3 (fr) | Nouvelles molecules de la famille de proteines apparentees a tango-93 et leurs utilisations | |
| WO2001094390A3 (fr) | 52906, 33408, et 12189, nouveaux elements de la famille de canaux de potassium et leurs utilisations | |
| WO2001083752A3 (fr) | 23949 et 32391, nouveaux canaux ioniques humains, et utilisation associee | |
| WO2001094412A3 (fr) | 56201 nouveau membre de la famille humaine des canaux d'ions sodium et leurs utilisations | |
| WO2001075076A3 (fr) | 33167, nouvelle hydrolase humaine, et utilisations associees | |
| WO2002020739A3 (fr) | 46798, nouvelle metalloproteinase matricielle humaine et ses utilisations | |
| WO2002006485A3 (fr) | 47885, une nouvelle enzyme activant l'ubiquitine humaine et ses applications | |
| WO2003020912A3 (fr) | Nouvelle proteine cark et molecules d'acides nucleiques et leurs utilisation | |
| WO2001066759A3 (fr) | 26886, nouvel element de la famille de la carnitine acyltransferase et ses utilisations | |
| WO2001066763A3 (fr) | 23436, nouveau membre de la famille des proteases d'ubiquitine humaine et utilisations de celui-ci | |
| WO2001059065A3 (fr) | Nouvelles molecules de la famille des proteines apparentees a card et leurs utilisations | |
| WO2002024898A3 (fr) | Nouvelle lipase humaine 47647 et utilisations | |
| WO2002034896A3 (fr) | 13245, une nouvelle proteine kinase humaine de type a dystrophie myotonique et ses utilisations | |
| WO2001081584A3 (fr) | 27960, nouvel element de la famille des enzymes de conjugaison a l'ubiquitine | |
| WO2002026948A3 (fr) | 55054, une nouvelle metalloprotease humaine et ses applications | |
| WO2002026958A3 (fr) | Nouvelle neprilysine protease humaine denommee 56638, et utilisations associees | |
| WO2002008394A3 (fr) | 23430, nouveau membre de la famille des ubiquitines hydrolases de l'homme et ses utilisations | |
| WO2002006331A3 (fr) | 14087, nouvelle molecule de serine protease, et utilisations associees | |
| WO2002024925A3 (fr) | Nouvelle tyrosine phosphatase humaine appelee 69109 et utilisations de cette derniere | |
| WO2001072828A3 (fr) | 26649, une nouvelle molecule activant la gtpase humaine et ses applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| COP | Corrected version of pamphlet |
Free format text: PAGES 1/11-11/11,DRAWINGS,REPLACED BY NEW PAGES 1-12-12/12;DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE |
|
| NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97516063 Format of ref document f/p: F |
|
| 122 | Ep: pct application non-entry in european phase |